For those who’re available in the market for some no-brainer dividend shares, I’ve some good and less-good information for you. The excellent news is that investing in wholesome and rising dividend-paying shares is a strong, no-brainer transfer — as a result of dividend payers could be highly effective investments. Sadly, although, hardly any inventory qualifies as a no brainer funding.
For finest outcomes, use your mind to observe and sustain with any firms through which you make investments. Listed here are a handful of strong dividend-paying contenders to your long-term portfolio.
Picture supply: Getty Photographs.
First, although, simply in case you are not fired up about dividend-paying shares, take a look at the desk beneath — as it would shock you.
Dividend-Paying Standing
Common Annual Whole Return, 1973-2024
Dividend growers and initiators
10.24%
Dividend payers
9.20%
No change in dividend coverage
6.75%
Dividend non-payers
4.31%
Dividend shrinkers and eliminators
(0.89%)
Equal-weighted S&P 500 index
7.65%
Knowledge supply: Ned Davis Analysis and Hartford Funds.
See? Dividend shares will not be simply to your grandparents. Their strong efficiency should not be shocking, both, as a result of for an organization’s administration to really feel safe about committing to an ongoing dividend fee, the corporate sometimes must have grown to a sure dimension with pretty dependable revenue. Listed here are some promising dividend payers to contemplate.
In line with our Motley Idiot Cash analysis, the most effective high-yield financial savings accounts supplied rates of interest of round 4% to 4.3% in January. Put money into shares of Pfizer(NYSE: PFE), although, and also you’re a fats dividend yield of, lately, 6.81%!
The inventory has been in a droop lately partly as a consequence of shrunken demand for its COVID-19 vaccine and COVID-19 remedy, Paxlovid, in addition to the expirations of patent safety for a number of key medication. However the firm has much more occurring than that — resembling some investments that may end up in an accepted GLP-1 weight-loss drug for Pfizer.
Pfizer’s inventory is attractive, too, with a latest forward-looking price-to-earnings (P/E) ratio of 8.5, properly beneath its five-year common of 9.8.
Verizon Communications(NYSE: VZ) sports activities a dividend lately yielding even extra than Pfizer: 6.93%! Higher nonetheless, Verizon has been growing its payout for 19 years in a row (although typically not with large will increase).
For those who’re searching for a quick grower, look elsewhere. Verizon is a money cow, although, amassing gobs of recurring income from its 146 million-some wi-fi accounts (as of October 2025). It boasts greater than one million miles of fiber and it covers 99% of the U.S. inhabitants with its 4G LTE community. Verizon was lately raking in additional than $130 billion in annual revenue and near $20 billion in web revenue.
Verizon’s inventory can be appealingly priced, with a latest forward-looking price-to-earnings (P/E) ratio of 8.2, beneath its five-year common of 8.8.
Then there’s United Parcel Service (NYSE: UPS), with a latest dividend yield of 6.1%. The corporate has been harm as Amazon has been sending it far fewer packages to ship, however UPS nonetheless has lots going for it. For instance, it sports activities an enormous fleet of 500-plus plane and as of 2024, some 135,000 floor autos. Its practically 500,000 staff delivered greater than 22 million gadgets in 2024 — every day.
With a latest a latest forward-looking price-to-earnings (P/E) ratio of 14.7, a bit beneath its five-year common of 15.4, UPS’ inventory appears attractively priced. However do be aware that the corporate is dealing with some challenges, together with slowing development and shrinking revenue margins. Administration is conscious of that, although, and is engaged on a turnaround, partly by reducing prices and including extra automation.
Any believers in UPS who purchase now can get pleasure from a beneficiant dividend fee each quarter whereas ready for a turnaround. Given the numerous dividend yields for every of those firms, and their probabilities to continue to grow, they appear like a number of the finest dividend shares to contemplate.
Before you purchase inventory in Pfizer, take into account this:
The Motley Idiot Inventory Advisor analyst crew simply recognized what they imagine are the 10 finest shares for traders to purchase now… and Pfizer wasn’t one in every of them. The ten shares that made the reduce might produce monster returns within the coming years.
Think about when Netflix made this listing on December 17, 2004… in the event you invested $1,000 on the time of our advice, you’d have $474,578!* Or when Nvidia made this listing on April 15, 2005… in the event you invested $1,000 on the time of our advice, you’d have $1,141,628!*
Now, it’s value noting Inventory Advisor’s whole common return is 955% — a market-crushing outperformance in comparison with 196% for the S&P 500. Do not miss the newest high 10 listing, out there with Inventory Advisor, and be a part of an investing neighborhood constructed by particular person traders for particular person traders.
*Inventory Advisor returns as of January 17, 2026.
Selena Maranjian has positions in Amazon, Pfizer, and Verizon Communications. The Motley Idiot has positions in and recommends Amazon, Pfizer, and United Parcel Service. The Motley Idiot recommends Verizon Communications. The Motley Idiot has a disclosure coverage.
